A protein kinase inhibitor, staurosporine, mimics nerve growth factor induction of neurotensin/neuromedin N gene expression.
Nerve growth factor (NGF) cooperates with glucocorticoids, activators of adenylate cyclase, and lithium to induce the expression of teh gene encoding the neuropeptides neurotensin and neuromedin N (NT/N gene) in PC 12 pheochromocytoma cells. High level expression requires simultaneous treatment with three or all four inducers. To examine the mechanism underlying this complex synergism, we have examined the effects of protein kinase inhibitors and other agents which influence intracellular signal transduction on NT/N gene expression. Two structurally similar bacterial alkaloids, staurosporine and K-252a, inhibit several protein kinases in vitro, including protein kinase C and cyclic nucleotide-dependent kinases. K-252a has been reported to specifically inhibit the effects of NGF on PC12 pheochromocytoma cells. Surprisingly, staurosporine in combination with other inducers markedly potentiated NT/N gene expression. In contrast, K-252a had no effect on NT/N gene expression when added simultaneously with other inducers. Expression of the NT/N gene was also potentiated by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate, which directly activates protein kinase C, and by bradykinin, which stimulates phosphatidylinositol turnover in PC12 cells, and these effects were not blocked by staurosporine. Staurosporine was generally more effective in stimulating NT/N gene expression when used in inducer combinations that did not include NGF. These results, taken together with recent evidence that staurosporine is also able to induce neurite outgrowth from PC12 cells, suggest that the effects of staurosporine and NGF may converge, in part, on a common intracellular target.
Tischler
A S
AS
Department of Pathology, Tufts University School of Medicine, Boston, Massachusetts 02111.
Ruzicka
L A
LA
Dobner
P R
PR
D000310:Adrenal Gland Neoplasms / Q000378:metabolism; D000470:Alkaloids / Q000494:pharmacology*; D001920:Bradykinin / Q000494:pharmacology; D005786:Gene Expression Regulation; D006801:Humans; D009414:Nerve Growth Factors / Q000494:pharmacology*; D009496:Neurotensin / Q000235:genetics*; D010446:Peptide Fragments / Q000235:genetics*; D010673:Pheochromocytoma / Q000378:metabolism; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D012313:RNA / Q000032:analysis; D015398:Signal Transduction / Q000187:drug effects; D019311:Staurosporine; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D000470:Alkaloids; D009414:Nerve Growth Factors; D010446:Peptide Fragments; C042090:neuromedin N; D009496:Neurotensin; D012313:RNA; D011493:Protein Kinase C; D019311:Staurosporine; D013755:Tetradecanoylphorbol Acetate; D001920:Bradykinin